BOUDOU-ROUQUETTE , Pascaline

Last name: BOUDOU-ROUQUETTE

First name: Pascaline

November 23, 2018 (v1)

Journal article

Metadata-only

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Duffaud, Florence Mir, Olivier Boudou-Rouquette, Pascaline

BACKGROUND: Regorafenib has proven activity in patients with pretreated gastrointestinal stromal tumours and colorectal and hepatocellular carcinoma. We designed REGOBONE to assess the efficacy and safety of regorafenib for patients with progressive metastatic osteosarcoma and other bone sarcomas. This trial comprised four parallel independent...

Uploaded on: March 8, 2024
June 2021 (v1)

Journal article

Metadata-only

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

Duffaud, Florence Italiano, Antoine Bompas, Emannuelle

International audience

Uploaded on: December 3, 2022
September 15, 2022 (v1)

Journal article

Metadata-only

Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis

Penel, Nicolas Bonvalot, Sylvie Bimbai, André-Michel

Abstract Purpose: This prospective nationwide cohort study aimed to investigate desmoid-type fibromatosis (DF) outcomes, focusing on the prognostic value of CTNNB1 mutations. Experimental Design: ALTITUDES (NCT02867033) was a nationwide prospective cohort study of DF diagnosed between January 2016 and December 2020. At diagnosis, CTNNB1...

Uploaded on: February 22, 2023

BOUDOU-ROUQUETTE , Pascaline

Recent uploads